Ledipasvir/sofosbuvir

Subarachnoid-haemorrhage, brain stem haemorrhage and development of drug resistance: 11 case reports

    Reactions Weekly volume 1843, page218(2021)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    US$ 49.95

    Tax calculation will be finalised during checkout.

    Reference

    1. Mizokami M, et al. Real-world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan. Journal of Viral Hepatitis 28: 129-141, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1111/jvh.13395

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Ledipasvir/sofosbuvir. Reactions Weekly 1843, 218 (2021). https://doi.org/10.1007/s40278-021-91320-1

    Download citation